Next-Generation Imaging

Latest News

First patient dosed with TLX250-CDx in Italy for ccRCC
First patient dosed with TLX250-CDx in Italy for ccRCC

March 25th 2024

With the dosing of the first patient in Italy, Telix’s expanded access program for TLX250-CDx in ccRCC now includes 3 active countries, including the Netherlands and the US.

Multi-dose phase of 64Cu/67Cu-SAR-bisPSMA study begins in mCRPC
Multi-dose phase of 64Cu/67Cu-SAR-bisPSMA study begins in mCRPC

March 18th 2024

Commercial supply of piflufolastat (18F) begins in Italy
Commercial supply of piflufolastat (18F) begins in Italy

March 8th 2024

Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
Dr. Reiter discusses accuracy of PSMA-PET scans

March 5th 2024

3d rendered medically accurate illustration of prostate cancer | Image Credit: @ SciePro - @ SciePro - stock.adobe.com
PSMA-PET leads imaging breakthroughs in prostate cancer paradigm

February 23rd 2024

More News

© 2024 MJH Life Sciences

All rights reserved.